![Lawrence Klein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lawrence Klein
Direktör/Styrelseledamot på
JADE BIOSCIENCES, INC.
Förmögenhet: 54 M $ per 2026-05-31
Profil
Lawrence O.
Klein is President, Chief Executive Officer & Director at Oruka Therapeutics, Inc. since 2024.
Dr. Klein is Independent Director at Jade Biosciences, Inc. starting in 2025.
Dr. Klein is Director at Jade Biosciences, Inc. (United States) since 2024.
Former roles include Chief Executive Officer & Director at Oruka Therapeutics, Inc. (Old);.
Independent Director at Dyne Therapeutics, Inc. from 2019 to 2023; Independent Director at Jasper Therapeutics, Inc. from 2021 to 2023; Associate Partner at Mckinsey & Co. (Switzerland) from 2014 to 2016; Partner at Versant Venture Management LLC from 2023 to 2024; and Chief Operating Officer at CRISPR Therapeutics AG from 2020 to 2022.
Education includes a doctorate from Stanford University and an undergraduate degree from the University of Wisconsin.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
1,91 % | 2026-06-15 | 925 580 ( 1,91 % ) | 54 M $ | 2026-05-31 |
| 2026-06-09 | 70 ( 0 % ) | 1 473 $ | 2026-05-31 |
Aktiva positioner av Lawrence Klein
| Företag | Position | Start |
|---|---|---|
| JADE BIOSCIENCES, INC. | Direktör/Styrelseledamot | 2025-04-28 |
Tidigare kända positioner av Lawrence Klein
| Företag | Position | Slut |
|---|---|---|
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Privat kapitalinvesterare | 2024-02-01 |
| JASPER THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2023-06-20 |
| DYNE THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2023-05-24 |
| CRISPR THERAPEUTICS AG | Verksamhetschef | 2022-10-01 |
Mckinsey & Co. (Switzerland)
 Mckinsey & Co. (Switzerland) Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Företagsledare/Principal | 2016-02-01 |
Lawrence Kleins utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
19
Första gradens relationer
8
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Mckinsey & Co. (Switzerland)
Mckinsey & Co. (Switzerland) Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Commercial Services |
Dyne Therapeutics, Inc.
 Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Jasper Therapeutics, Inc.
 Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
